Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China
· Delayed Price · Currency is CNY 40.63
+0.91 (2.29%)
Mar 10, 2026, 10:14 AM CST
SHA:603590 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,316 | 3,724 | 5,959 | 3,903 | 5,084 | 5,843 | Upgrade
|
| Market Cap Growth | 66.76% | -37.51% | 52.69% | -23.24% | -12.98% | 4.58% | Upgrade
|
| Enterprise Value | 5,965 | 3,614 | 5,764 | 3,593 | 4,468 | 4,318 | Upgrade
|
| Last Close Price | 39.72 | 23.07 | 36.90 | 24.02 | 30.95 | 34.89 | Upgrade
|
| PE Ratio | 109.23 | 88.21 | 39.61 | 38.46 | 34.36 | 31.87 | Upgrade
|
| PS Ratio | 7.25 | 4.51 | 6.48 | 4.50 | 6.28 | 7.23 | Upgrade
|
| PB Ratio | 1.81 | 1.09 | 1.77 | 1.22 | 1.62 | 1.90 | Upgrade
|
| P/TBV Ratio | 2.67 | 1.62 | 2.83 | 1.94 | 2.57 | 2.70 | Upgrade
|
| P/FCF Ratio | 101.51 | 54.59 | 60.54 | 166.94 | - | 727.44 | Upgrade
|
| P/OCF Ratio | 43.73 | 21.62 | 29.89 | 32.61 | 90.44 | 100.04 | Upgrade
|
| EV/Sales Ratio | 6.85 | 4.38 | 6.27 | 4.15 | 5.52 | 5.34 | Upgrade
|
| EV/EBITDA Ratio | 35.30 | 24.63 | 34.86 | 23.71 | 30.97 | 30.47 | Upgrade
|
| EV/EBIT Ratio | 42.10 | 30.43 | 44.49 | 30.07 | 39.71 | 38.66 | Upgrade
|
| EV/FCF Ratio | 95.88 | 52.97 | 58.55 | 153.69 | - | 537.53 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.06 | 0.05 | 0.00 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.66 | 1.38 | 0.87 | 0.08 | 0.13 | 0.17 | Upgrade
|
| Debt / FCF Ratio | 4.51 | 3.07 | 1.52 | 0.53 | - | 3.05 | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.14 | -0.20 | -0.19 | -0.19 | -0.49 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.90 | -3.30 | -4.00 | -4.05 | -4.16 | -10.61 | Upgrade
|
| Net Debt / FCF Ratio | -10.26 | -7.11 | -6.71 | -26.26 | 5.54 | -187.19 | Upgrade
|
| Asset Turnover | 0.22 | 0.21 | 0.26 | 0.26 | 0.23 | 0.23 | Upgrade
|
| Inventory Turnover | 1.43 | 1.43 | 2.37 | 3.02 | 2.61 | 2.46 | Upgrade
|
| Quick Ratio | 2.95 | 2.80 | 3.49 | 5.51 | 5.62 | 2.97 | Upgrade
|
| Current Ratio | 3.12 | 3.08 | 3.80 | 5.90 | 6.12 | 3.04 | Upgrade
|
| Return on Equity (ROE) | 0.92% | 0.63% | 5.73% | 3.92% | 5.39% | 6.31% | Upgrade
|
| Return on Assets (ROA) | 2.20% | 1.93% | 2.25% | 2.20% | 1.97% | 2.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.82% | 2.33% | 4.91% | 4.13% | 4.85% | 7.79% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.30% | 3.70% | 3.70% | 3.50% | 3.50% | Upgrade
|
| Earnings Yield | 0.90% | 1.13% | 2.53% | 2.60% | 2.91% | 3.14% | Upgrade
|
| FCF Yield | 0.99% | 1.83% | 1.65% | 0.60% | -2.13% | 0.14% | Upgrade
|
| Dividend Yield | 1.47% | 2.60% | 0.81% | 0.83% | 0.97% | 1.00% | Upgrade
|
| Payout Ratio | 165.00% | 126.71% | 23.23% | 46.26% | 37.58% | 43.63% | Upgrade
|
| Buyback Yield / Dilution | -0.03% | 0.23% | -0.37% | 0.82% | 1.26% | 0.53% | Upgrade
|
| Total Shareholder Return | 1.44% | 2.83% | 0.44% | 1.65% | 2.23% | 1.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.